Nav: Home

Maintaining healthy DNA delays menopause

September 28, 2015

An international study of nearly 70,000 women has identified more than forty regions of the human genome that are involved in governing at what age a woman goes through the menopause. The study, led by scientists at the Universities of Cambridge and Exeter, found that two thirds of those regions contain genes that act to keep DNA healthy, by repairing the small damages that can accumulate with age. The study also found the first genetic evidence of a link between the timing of menopause and breast cancer, corroborating previous conclusions from observational evidence.

The findings, published today (September 28) in Nature Genetics, suggest that the reproductive cells or "eggs" in a woman's ovaries (known as oocytes) that repair damaged DNA more efficiently survive longer. This results in a later age at menopause, which marks the end of a woman' reproductive lifetime. Previous research has shown that DNA is regularly damaged by age and by toxic substances such as cigarette smoke - hence women who smoke go through menopause 1-2 years earlier on average than non-smokers. Our cells have many mechanisms to detect and repair such damage, but cells die when too much damage accumulates. DNA is also damaged and repaired during the production of eggs, therefore these genes might also act to enhance a woman's pool of eggs which is set in early life.

In a collaboration involving scientists from 177 institutions worldwide, the authors undertook a genome-wide association study of almost 70,000 women of European ancestry.

Dr Anna Murray, a geneticist from the University of Exeter Medical School, and senior author on the paper, described the impact of the findings: "Many women today are choosing to have babies later in life, but they may find it difficult to conceive naturally because fertility starts to diminish at least 10 years before menopause. Our research has substantially increased our understanding of how reproductive ageing in women happens, which we hope will lead to the development of new treatments to avoid early menopause."

Dr John Perry from the Medical Research Council (MRC) Epidemiology Unit at the University of Cambridge co-led the study, and said:

"We have known for some time that the age at which women go through menopause is partly determined by genes. This study now tells us that there are likely hundreds of genes involved, each altering menopause age by anything from a few weeks to a year. It is striking that genes involved in DNA repair have such an important influence on the age of menopause, which we think is due to their effect on how quickly a woman's eggs are lost throughout her lifetime."

Whilst previous research has observed that an earlier menopause reduces a woman's risk of developing breast cancer, this is the first study to confirm the link using genetic information. The researchers predict that every one year later that menopause occurs increases the risk of developing breast cancer by 6%.

Dr Deborah Thompson from the Department of Public Health and Primary Care at the University of Cambridge also co-led this large international collaboration and said: "One particularly convincing finding was that going through menopause earlier reduces your chances of developing breast cancer and we think this is because these women have less exposure to the hormone oestrogen over their lifetime."

The next step is to understand in more detail how the genetic variations found in this study are causing alterations in the timing of menopause. Uncovering these mechanisms will hopefully lead to better treatment for conditions linked to menopause, such as infertility and also improved understanding of the heath impact of menopause, such as risk of osteoporosis and heart disease.

Menopause usually occurs between ages 40 to 60 years old, indicated by the end of natural menstrual cycles and in many women by physical symptoms, such as hot flushes, disrupted sleep, and reduced energy levels. Natural menopause before the age of 40 is often called primary ovarian insufficiency and occurs in 1% of women.
-end-


University of Exeter

Related Breast Cancer Articles:

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
Blood test offers improved breast cancer detection tool to reduce use of breast biopsy
A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.
More Breast Cancer News and Breast Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.